Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Koninklijke Philips N.V.    PHIA   NL0000009538


News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Koninklijke Philips N : Philips warns protectionism could derail critical medical supplies

share with twitter share with LinkedIn share with facebook
share via e-mail
03/24/2020 | 11:52am EDT
FILE PHOTO: Dutch health technology company Philips presents the company's financial results for the fourth quarter in Amsterdam

Broad powers over U.S. factories brought in by President Donald Trump could fuel protectionism and jeopardize the supply of critical medical equipment to fight the coronavirus pandemic, Dutch health technology company Philips warned on Tuesday.

Trump said on Friday he had put into action the U.S. Defense Production Act, a law dating back to the Korean War of the 1950s that grants him sweeping authority to expedite and expand the supply of resources from U.S. factories.

That could include hospital ventilators which Philips makes in factories in California and Pennsylvania.

"We are worried", Philips spokesman Steve Klink told Reuters on Tuesday, referring to the act.

Amsterdam-based Philips said on Sunday it would increase production of critical medical supplies for the diagnosis and care of patients with the new coronavirus disease COVID-19.

Most importantly, it said it would double its production of hospital ventilators in the coming weeks to help meet soaring global demand, and was aiming at a four-fold increase by the third quarter.

All these ventilators, however, are produced in its two U.S. factories, which makes Philips' promise to ship them to the regions where they are most needed vulnerable to interventions by the U.S. government.

Such interventions could not only limit supply outside the United States, Klink said, but could also leave the country itself with less equipment than it would otherwise have - if retaliation in Europe or Asia squeezed the supply of critical parts.

"We know we can meet our production promises", Klink said.

"But only if the entire supply chain cooperates. A respiratory device has many parts, which come from all over the world. Protectionism can have a detrimental effect, no matter if it happens at the end of the production line or somewhere in between."

In a tweet posted on Tuesday, Trump said the Defense Production Act was in full force, but had not been used yet.

A few hours later, CNN reported the Trump administration was planning to procure 60,000 coronavirus test kits through the first use of the act.

The Dutch ministry of foreign affairs said it was in talks with both Philips and the Trump administration on the matter, but declined further comment.

Philips said it was optimistic its exports of ventilators would be unaffected, as Chief Executive Frans van Houten continued to be in talks with the U.S. government.

"As long as we are in talks, we remain confident in a positive outcome."

(Reporting by Bart Meijer; Editing by Mark Potter)

By Bart H. Meijer

share with twitter share with LinkedIn share with facebook
share via e-mail
10:36aKLM and Philips to set up a special freight airlift from Amsterdam to China
05:20aPHILIPS NV : UBS reiterates its Buy rating
04:28aKONINKLIJKE PHILIPS N : COVID-19 treatment depends on international collaboratio..
04/08KONINKLIJKE PHILIPS N : Philips says U.S. deal will enable it to ramp up ventila..
04/08KONINKLIJKE PHILIPS N : GM, Philips to supply 73,000 U.S. ventilators in $1.1 bi..
04/08Philips and the U.S. government collaborate in ventilator production ramp up ..
04/07PHILIPS NV : JP Morgan reiterates its Neutral rating
04/02FDA's enforcement discretion allowing to expand remote use of Philips Intelli..
04/01Philips enables hospitals and GPs to remotely screen and monitor patients wit..
03/31KONINKLIJKE PHILIPS N : Philips statement on its ongoing collaboration with HHS ..
More news
Financials (EUR)
Sales 2020 20 110 M
EBIT 2020 2 604 M
Net income 2020 1 404 M
Debt 2020 3 714 M
Yield 2020 2,35%
P/E ratio 2020 24,7x
P/E ratio 2021 18,9x
EV / Sales2020 1,85x
EV / Sales2021 1,70x
Capitalization 33 525 M
Duration : Period :
Koninklijke Philips N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KONINKLIJKE PHILIPS N.V.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 23
Average target price 42,02  €
Last Close Price 37,77  €
Spread / Highest target 37,7%
Spread / Average Target 11,3%
Spread / Lowest Target -34,4%
EPS Revisions
Frans van Houten Chief Executive Officer
Jeroen van der Veer Chairman-Supervisory Board
Sophie Bechu Chief Operating Officer & Executive Vice President
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Jan Kimpen Chief Medical Officer
Sector and Competitors